3.98
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LFMD Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.935
Aprire:
$3.98
Volume 24 ore:
1.11M
Relative Volume:
0.95
Capitalizzazione di mercato:
$191.58M
Reddito:
$193.06M
Utile/perdita netta:
$-22.51M
Rapporto P/E:
-6.2188
EPS:
-0.64
Flusso di cassa netto:
$10.63M
1 W Prestazione:
+32.67%
1M Prestazione:
+43.17%
6M Prestazione:
-31.38%
1 anno Prestazione:
-29.68%
Lifemd Inc Stock (LFMD) Company Profile
Nome
Lifemd Inc
Settore
Industria
Telefono
(866) 351-5907
Indirizzo
236 FIFTH AVENUE, NEW YORK
Compare LFMD vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
LFMD
Lifemd Inc
|
3.98 | 191.58M | 193.06M | -22.51M | 10.63M | -0.64 |
|
VEEV
Veeva Systems Inc
|
178.88 | 29.40B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
49.98 | 8.94B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
38.31 | 7.36B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
77.81 | 6.65B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.16 | 4.63B | 1.10B | 112.09M | 283.19M | 0.6096 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-18 | Reiterato | BTIG Research | Buy |
| 2024-12-10 | Iniziato | Lake Street | Buy |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-08-23 | Ripresa | B. Riley Securities | Buy |
| 2024-06-05 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2023-11-30 | Iniziato | Craig Hallum | Buy |
| 2023-07-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-07-03 | Iniziato | H.C. Wainwright | Buy |
| 2022-03-10 | Iniziato | Colliers Securities | Buy |
| 2021-10-04 | Ripresa | B. Riley Securities | Buy |
Mostra tutto
Lifemd Inc Borsa (LFMD) Ultime notizie
LifeMD (LFMD) Is Up 32.7% After Returning To Profitability And Expanding GLP‑1 Telehealth Offerings - simplywall.st
LifeMD (NASDAQ:LFMD) Upgraded to Hold at Wall Street Zen - MarketBeat
H.C. Wainwright raises LifeMD stock price target to $10 on results - Investing.com Nigeria
HC Wainwright Issues Positive Forecast for LifeMD Earnings - MarketBeat
A Look At LifeMD (LFMD) Valuation After Profitability Return And 2026 Growth Guidance - Yahoo Finance
LifeMD outlines $250M+ annualized revenue run rate target by Q4 2026 amid record GLP-1 demand and expanded partnerships - MSN
LifeMD (LFMD) Valuation Check After Earnings Beat Guidance Update And Wegovy Partnership - simplywall.st
Hims & Hers Plunges 29.4% in Three Months: How to Play the Stock? - TradingView
Freedom Capital Markets raises LifeMD stock price target on forecast boost By Investing.com - Investing.com South Africa
Freedom Capital Markets raises LifeMD stock price target on forecast boost - Investing.com
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Centene (CNC) and LifeMD (LFMD) - The Globe and Mail
LifeMD: Wegovy Pill, Net Cash, And Low Multiple Sets Up Longs For Possible Alpha - Seeking Alpha
LifeMD, Inc. 2025 Annual Report: Virtual Healthcare, Telehealth Growth, and Integrated Pharmacy Platform 101 - Minichart
HC Wainwright Increases LifeMD (NASDAQ:LFMD) Price Target to $10.00 - MarketBeat
LifeMD (LFMD): HC Wainwright Raises Price Target While Maintaini - GuruFocus
LifeMD (LFMD) Trailing Losses Narrow To US$14.6m Challenging Bearish Profitability Narratives - Sahm
Cantor Fitzgerald Maintains Overweight on LifeMD, Inc. (LFMD) March 2026 - Meyka
LifeMD 10-K: Telehealth revenue $194.1M, Net income $15.62M - TradingView
LifeMD Issues 2026 Outlook Amid Strong 2025 Growth - The Globe and Mail
LifeMD (NASDAQ: LFMD) grows 2025 telehealth revenue 25% as losses narrow - Stock Titan
LifeMD (LFMD) Soars After Strong Q4 Results and Positive Outlook - GuruFocus
Cantor Fitzgerald reiterates Overweight on LifeMD stock, $15 target By Investing.com - Investing.com Australia
LifeMD soars as Cantor Fitzgerald reportedly reiterates Overweight rating following solid Q4 print - Seeking Alpha
Cantor Fitzgerald reiterates Overweight on LifeMD stock, $15 target - Investing.com
BTIG Research Reiterates Buy Rating for LifeMD (NASDAQ:LFMD) - MarketBeat
LifeMD (LFMD) Receives Analyst Rating Reiteration from BTIG | LF - GuruFocus
LifeMD options imply 10.9% move in share price post-earnings - TipRanks
LifeMD rises on Q4 2025 beats, 2026 revenue guidance midpoint above consensus - MSN
LifeMD Inc (LFMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
LifeMD Q4 2025 Earnings Call Transcript - MarketBeat
LifeMD Inc (LFMD) Q4 2025 Earnings Call Highlights: Strong Reven - GuruFocus
LifeMD Inc reports results for the quarter ended December 31Earnings Summary - TradingView
LifeMD (LFMD) Reports Strong Growth and Strategic Partnerships - GuruFocus
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates - Bitget
LifeMD Q4 Earnings Call Highlights - MarketBeat
LifeMD (LFMD) Shares Surge After Beating Q4 2025 Expectations - GuruFocus
LifeMD earnings beat by $0.03, revenue fell short of estimates - Investing.com Canada
LifeMD: Q4 Earnings Insights - Benzinga
LifeMD reports Q4 EPS 41c, consensus 3c - TipRanks
LifeMD (LFMD) Reports Strong Q4 Revenue and Expanding Telehealth Subscriber Base - GuruFocus
LifeMD (LFMD) Projects Q1 EBITDA Loss, Anticipates Rebound in Q2 - GuruFocus
LifeMD (LFMD) Projects Strong Financial Growth for 2026 - GuruFocus
LifeMD surges 11.5% on Q4 earnings beat, FY guidance - Investing.com South Africa
LifeMD (NASDAQ:LFMD) Releases Quarterly Earnings Results, Beats Expectations By $0.42 EPS - MarketBeat
LIFEMD ($LFMD) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
LifeMD 2025 revenue jumps 25% to $194M, guides 2026 - National Today
[8-K] LifeMD, Inc. Reports Material Event | LFMD SEC FilingForm 8-K - Stock Titan
LifeMD Q4 revenue rises but misses estimates - TradingView
LifeMD Reports Fourth Quarter and Full Year 2025 Results - marketscreener.com
LifeMD, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2026 - marketscreener.com
BREAKING: LFMD Reports Q4 Earnings - AlphaStreet
Lifemd Inc Azioni (LFMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):